LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC said Friday it has launched in the European market its non-invasive test to diagnose diseases such as Cushing's Syndrome.
The test, which uses the company's IDS-iSYS automated system, checks the level of the hormone cortisol in saliva, which can then be used as a way to diagnose diseases of cortisol imbalance such as Cushing's Syndrome.
Shares in Immunodiagnostic were untraded Friday morning, having last closed at 240.75 pence.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
